Women with Acromegaly Face Greater Risk of Progressive Joint Pain and Mood Issues
42-month study reveals female sex and radiotherapy predict worsening joint symptoms in acromegaly patients, with suicide emerging as notable cause of death.
Summary
A 42-month study of 95 acromegaly patients found that women experience significantly worse progression of joint pain and psychological symptoms compared to men. Prior radiotherapy treatment also predicted worsening joint problems. Surprisingly, patients whose disease returned actually had less joint pain, while those achieving remission saw mood improvements. Dopamine agonist medications were linked to increased depression scores. Most concerning, suicide emerged as a notable cause of death in this patient group, highlighting the serious psychological burden of this growth hormone disorder.
Detailed Summary
This Italian multicenter study tracked 95 acromegaly patients for 42 months to understand how joint pain and psychological complications progress over time. Acromegaly, caused by excess growth hormone, creates debilitating joint problems and mood disorders that severely impact quality of life.
Researchers used validated questionnaires to assess joint symptoms, psychological wellbeing, and quality of life at baseline and follow-up. They excluded patients with inflammatory rheumatic diseases to isolate acromegaly-specific effects.
Key findings revealed striking sex differences: women experienced significantly worse progression of joint symptoms compared to men. Prior radiotherapy treatment also predicted deteriorating joint health. Counterintuitively, patients whose disease recurred showed improved joint pain scores, while those achieving disease remission experienced better mood outcomes. Dopamine agonist medications were associated with higher depression scores.
Most alarming was the emergence of suicide as a relevant cause of death in this cohort, underscoring the severe psychological burden these patients face. Joint disease had a greater negative impact on quality of life than mood disorders, though both were significant.
For longevity and health optimization, this research highlights the importance of comprehensive care addressing both physical and psychological aspects of hormonal disorders. The sex-specific differences suggest women may need more aggressive joint protection strategies and psychological support when managing acromegaly.
Key Findings
- Women with acromegaly experience significantly worse progression of joint symptoms than men
- Prior radiotherapy treatment predicts worsening joint problems over time
- Dopamine agonist medications may negatively impact mood and increase depression scores
- Disease remission improves psychological symptoms while recurrence paradoxically reduces joint pain
- Suicide emerged as a notable cause of death, highlighting severe psychological burden
Methodology
Multicenter prospective observational study following 95 acromegaly patients for 42 months. Used validated questionnaires (WOMAC, AIMS, VAS, AcroQoL) to assess joint symptoms, psychological status, and quality of life. Excluded patients with inflammatory rheumatic diseases.
Study Limitations
Relatively small sample size of 95 patients limits generalizability. Observational design cannot establish causation. Study focused on Italian population which may not represent global acromegaly patients.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.